143 related articles for article (PubMed ID: 32939130)
1. Development and Statistical Optimization of Solid Lipid Nanoparticle Formulations of Fluticasone Propionate.
Amasya G; Şengel TÜrk CT; Badilli U; Tarimci N
Turk J Pharm Sci; 2020 Aug; 17(4):359-366. PubMed ID: 32939130
[TBL] [Abstract][Full Text] [Related]
2. Novel Solid Lipid Nanocarrier of Glibenclamide: A Factorial Design Approach with Response Surface Methodology.
Pandey S; Patel P; Gupta A
Curr Pharm Des; 2018; 24(16):1811-1820. PubMed ID: 29788881
[TBL] [Abstract][Full Text] [Related]
3. Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin.
Abul Kalam M; Sultana Y; Ali A; Aqil M; Mishra AK; Aljuffali IA; Alshamsan A
J Biomed Mater Res A; 2013 Jun; 101(6):1813-27. PubMed ID: 23255511
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine a loaded solid lipid nanoparticles: optimization of formulation, process variable and characterization.
Varia JK; Dodiya SS; Sawant KK
Curr Drug Deliv; 2008 Jan; 5(1):64-9. PubMed ID: 18220553
[TBL] [Abstract][Full Text] [Related]
5. Development of Dapagliflozin Solid Lipid Nanoparticles as a Novel Carrier for Oral Delivery: Statistical Design, Optimization, In-Vitro and In-Vivo Characterization, and Evaluation.
Unnisa A; Chettupalli AK; Al Hagbani T; Khalid M; Jandrajupalli SB; Chandolu S; Hussain T
Pharmaceuticals (Basel); 2022 May; 15(5):. PubMed ID: 35631394
[TBL] [Abstract][Full Text] [Related]
6. Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells.
Vieira AC; Chaves LL; Pinheiro M; Ferreira D; Sarmento B; Reis S
Int J Nanomedicine; 2016; 11():2601-17. PubMed ID: 27354792
[TBL] [Abstract][Full Text] [Related]
7. Characterization and stability of nanostructured lipid carriers as drug delivery system.
Abbasalipourkabir R; Salehzadeh A; Abdullah R
Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544
[TBL] [Abstract][Full Text] [Related]
8. Formulation, Characterization, and Evaluation of Eudragit-Coated Saxagliptin Nanoparticles Using 3 Factorial Design Modules.
Alhamhoom Y; Ravi G; Osmani RAM; Hani U; Prakash GM
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364338
[No Abstract] [Full Text] [Related]
9. Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation.
Yadav KS; Sawant KK
Curr Drug Deliv; 2010 Jan; 7(1):51-64. PubMed ID: 20044908
[TBL] [Abstract][Full Text] [Related]
10. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
11. Optimization of linalool-loaded solid lipid nanoparticles using experimental factorial design and long-term stability studies with a new centrifugal sedimentation method.
Pereira I; Zielińska A; Ferreira NR; Silva AM; Souto EB
Int J Pharm; 2018 Oct; 549(1-2):261-270. PubMed ID: 30075252
[TBL] [Abstract][Full Text] [Related]
12. Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers.
Thatipamula R; Palem C; Gannu R; Mudragada S; Yamsani M
Daru; 2011; 19(1):23-32. PubMed ID: 22615636
[TBL] [Abstract][Full Text] [Related]
13. Potential enhancement of metformin hydrochloride in solidified reverse micellar solution-based PEGylated lipid nanoparticles targeting therapeutic efficacy in diabetes treatment.
Kenechukwu FC; Nnamani DO; Duhu JC; Nmesirionye BU; Momoh MA; Akpa PA; Attama AA
Heliyon; 2022 Mar; 8(3):e09099. PubMed ID: 35309393
[TBL] [Abstract][Full Text] [Related]
14. Optimization and characterization of ultrasound assisted preparation of curcumin-loaded solid lipid nanoparticles: Application of central composite design, thermal analysis and X-ray diffraction techniques.
Behbahani ES; Ghaedi M; Abbaspour M; Rostamizadeh K
Ultrason Sonochem; 2017 Sep; 38():271-280. PubMed ID: 28633826
[TBL] [Abstract][Full Text] [Related]
15. Solid Lipid Nanoparticles of Atovaquone Based on 2(4) Full-Factorial Design.
Mohtar N; A K Khan N; Darwis Y
Iran J Pharm Res; 2015; 14(4):989-1000. PubMed ID: 26664366
[TBL] [Abstract][Full Text] [Related]
16. Lyophilized Nasal Inserts of Atomoxetine HCl Solid Lipid Nanoparticles for Brain Targeting as a Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): A Pharmacokinetics Study on Rats.
Teaima MH; El-Nadi MT; Hamed RR; El-Nabarawi MA; Abdelmonem R
Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259468
[TBL] [Abstract][Full Text] [Related]
17. Design and Optimization of Febuxostat-loaded Nano Lipid Carriers Using Full Factorial Design.
Bhatt S; Sharma JB; Kamboj R; Kumar M; Saini V; Mandge S
Turk J Pharm Sci; 2021 Feb; 18(1):61-67. PubMed ID: 33633486
[TBL] [Abstract][Full Text] [Related]
18. Formulation and Optimization of Topical Solid Lipid Nanoparticles based Gel of Dapsone Using Design of Experiment.
Deshkar SS; Bhalerao SG; Jadhav MS; Shirolkar SV
Pharm Nanotechnol; 2018; 6(4):264-275. PubMed ID: 30394227
[TBL] [Abstract][Full Text] [Related]
19. Optimizing SLN and NLC by 2(2) full factorial design: effect of homogenization technique.
Severino P; Santana MH; Souto EB
Mater Sci Eng C Mater Biol Appl; 2012 Aug; 32(6):1375-9. PubMed ID: 24364934
[TBL] [Abstract][Full Text] [Related]
20. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
